Discover
HCWB
HCW Biologics Inc.
4.58
2 x 3.47
2 x 5.61
bid
ask
-
0.41
8.22%
2 @ 04:00 AM
4.56 -0.02 (0.52%)
| Ytd | 371.68% | |
| 1y | 22.13% |
4.39
day range
4.98
1.50
52 week range
44.10
| Open | 4.86 | Prev Close | 4.99 | Low | 4.39 | High | 4.98 | Mkt Cap | 7.31M |
| Vol | 72.39K | Avg Vol | 2.15M | EPS | -49.74 | P/E | N/A | Forward P/E | -0.73 |
| Beta | 0.84 | Short Ratio | 0.28 | Inst. Own | 3.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 6.58 | 200-d Avg | 10.30 | 1yr Est | 3.00 |
| Income Statement | |||
| Total Revenue | 6.53M | ||
| Revenues (USD) | 6.53M | ||
| Gross Profit | 6.53M | ||
| Operating Expenses | 3.30M | ||
| Research and Development Expense | 1.26M | ||
| Selling, General and Administrative Expense | 1.83M | ||
| Operating Income | 3.24M | ||
| Interest Expense | 109.27K | ||
| Income Tax Expense | 330.19K | ||
| Net Income | 3.47M | ||
| Net Income Common Stock | 1.98M | ||
| Net Income Common Stock (USD) | 1.98M | ||
| Consolidated Income | 3.47M | ||
| Earnings per Basic Share | 0.37 | ||
| Earnings per Basic Share (USD) | 0.37 | ||
| Earnings per Diluted Share | 0.37 | ||
| Earning Before Interest & Taxes (EBIT) | 3.91M | ||
| Earning Before Interest & Taxes (USD) | 3.91M | ||
| Preferred Dividends Income Statement Impact | 1.49M | ||
| Weighted Average Shares | 5.43M | ||
| Weighted Average Shares Diluted | 5.43M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.23M | ||
| Cash and Equivalents (USD) | 1.23M | ||
| Investments | 4.83M | ||
| Investments Non-Current | 4.83M | ||
| Trade and Non-Trade Receivables | 74.84K | ||
| Current Assets | 1.72M | ||
| Property, Plant & Equipment Net | 20.77M | ||
| Total Assets | 27.34M | ||
| Debt Current | 6.58M | ||
| Total Debt | 6.58M | ||
| Current Liabilities | 19.96M | ||
| Total Liabilities | 21.58M | ||
| Accumulated Retained Earnings (Deficit) | -105.04M | ||
| Shareholders Equity | 5.76M | ||
| Shareholders Equity (USD) | 5.76M | ||
| Assets Non-Current | 25.62M | ||
| Total Debt (USD) | 6.58M | ||
| Deferred Revenue | 470.00K | ||
| Liabilities Non-Current | 1.62M | ||
| Trade and Non-Trade Payables | 11.79M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 142.05K | ||
| Net Cash Flow from Financing | 851.64K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -723.58K | ||
| Issuance (Purchase) of Equity Shares | 1.11M | ||
| Issuance (Repayment) of Debt Securities | -259.30K | ||
| Net Cash Flow from Operations | -1.58M | ||
| Share Based Compensation | 10.02K | ||